Harpoon Therapeutics Inc (DELISTED) (HARP:DL)
23.01
0.00 (0.00%)
USD |
NASDAQ |
Mar 11, 16:00
Harpoon Therapeutics Revenue (Annual): 31.92M for Dec. 31, 2022
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2022 | 31.92M |
December 31, 2021 | 23.65M |
December 31, 2020 | 17.44M |
Date | Value |
---|---|
December 31, 2019 | 5.777M |
December 31, 2018 | 4.75M |
December 31, 2017 | 0.708M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
5.777M
Minimum
2019
31.92M
Maximum
2022
19.70M
Average
20.55M
Median
Revenue (Annual) Benchmarks
Merck & Co Inc | 60.12B |
Axonics Inc | 366.38M |
Johnson & Johnson | 85.16B |
Boston Scientific Corp | 14.24B |
Ambrx Biopharma Inc (DELISTED) | 7.402M |